Goodbye job applications, hello dream career
Seize control of your career and design the future you deserve with LW career
GET STARTED

ANSTO extends partnership with ITM

The Australian Nuclear Science and Technology Organisation has secured a long-term IP and technology license agreement with a Germany-based company.

user iconNaomi Neilson • 23 March 2022 • Big Law
ANSTO extends partnership with ITM
expand image

Firm: Maddocks (ANSTO)

You’re out of free articles for this month
Deal: Maddocks has advised the Australian Nuclear Science and Technology Organisation (ANSTO) on a new long-term IP and technology license agreement with leading German radiopharmaceutical biotech company ITM Isotope Technologies Munich SE.

Value: N/A

Area: IP

Key players: The team was led by IP and life sciences partner Ben Miller, who was assisted by lawyer Sophie Vo and the firms’ IP and pharma regulatory team.

Deal significance: The continuation of ANSTO’s longstanding partnership with ITM is significant as it allows local manufacturing to continue to support the growing demands of patients in the Australia-New Zealand region.

Naomi Neilson

Naomi Neilson

Naomi Neilson is a senior journalist with a focus on court reporting for Lawyers Weekly. 

You can email Naomi at: This email address is being protected from spambots. You need JavaScript enabled to view it.

Tags
You need to be a member to post comments. Become a member for free today!